HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia]

AbstractIn normoxic rabbits, the intravenous injection (1 mg/kg) of the product (almitrine + raubasine) do not modify the erythrocytic level of 2,3-DPG. But, after hypoxia (the rabbits being submitted to an oxygen pressure of 7,8 kPa during 20 minutes) the same dose of this product induce a durable rise of erythrocytic 2,3-DPG level which remain, 24 hours latter, + 15% above normal.
AuthorsA Callis, M Dorance, B Magnan de Bornier
JournalComptes rendus des séances de la Société de biologie et de ses filiales (C R Seances Soc Biol Fil) Vol. 174 Issue 6 Pg. 1006-9 ( 1980) ISSN: 0037-9026 [Print] FRANCE
Vernacular TitleEffet d'un oxygénateur tissulaire (almitrine + raubasine) sur le métabolisme du 2,3-diphosphoglycérate du lapin soumis à une hypoxie.
PMID6451260 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Diphosphoglyceric Acids
  • Piperazines
  • Secologanin Tryptamine Alkaloids
  • Triazines
  • Yohimbine
  • Almitrine
  • ajmalicine
  • Oxygen
Topics
  • Almitrine
  • Animals
  • Anoxia (blood)
  • Diphosphoglyceric Acids (blood)
  • Erythrocytes (drug effects, metabolism)
  • Kinetics
  • Oxygen (blood)
  • Partial Pressure
  • Piperazines (pharmacology)
  • Rabbits
  • Secologanin Tryptamine Alkaloids
  • Triazines (pharmacology)
  • Yohimbine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD